About this trial
This phase II trial compares the safety, side effects and effectiveness of reduced dose radiation therapy to standard of care dose radiation in treating patients with indolent non-Hodgkin lymphoma. Radiation therapy uses high energy x-rays, particles, or radioactive seeds to kill cancer cells and shrink tumors. Standard of care radiation treatment for indolent non-Hodgkin lymphoma is usually delivered in 12 treatments. Studies have shown indolent lymphoma to be sensitive to radiation treatment, however, larger doses have higher rates of toxicities. A reduced radiation dose may be safe, tolerable and/or effective compared to standard of care radiation dose in treating patients with indolent non-Hodgkin lymphoma.
Eligibility criteria
Qualifiers
Age ≥ 18 years
Follicular lymphoma (grade 1 or 2 or 3A)
Marginal zone lymphoma (nodal or extranodal)
Follicle center lymphoma
Disqualifiers
Pregnant women
Nursing women
Women of childbearing potential who are unwilling to employ adequate contraception
T-cell lymphoma
Trial design
Treatments tested in this trial
- Computed Tomography
- Endoscopic Procedure
- Involved-site Radiation Therapy (3 Fractions)
- Involved-site Radiation Therapy (12 Fractions)
- Positron Emission Tomography
- Questionnaire Administration